Par Pharmaceuticals announced it has begun shipment of Candesartan Cilexetil Tablets, the generic version of AstraZeneca’s Atacand. Atacand is an angiotensin II receptor blocker indicated for the treatment of hypertension in adults and children 1 to <17 years old and for the treatment of heart failure (NYHA Class II–IV).

Candesartan cilexetil blocks the vasoconstrictor and aldosterone-secreting effects of angiotensin II by selectively blocking the binding of angiotensin II to the AT1 receptor in many tissues, such as vascular smooth muscle and the adrenal gland.

Candesartan Cilexetil Tablets are available in 4mg, 8mg, 16mg, and 32mg strengths.

For more information call (800) 828-9393 or visit